{"summary":"Experience pharmaceutical professional, with 18 years of experience in pharmaceutical drug development (small molecule and biologics). GMP (analytical , manufacturing), Quality Control and Compliance,  Method Validation, Cleaning Validation, Change Management, PAI, Post Approval Changes, Tech transfers and Regulatory Affairs.  ","lastName":"Prashad","objectUrn":"urn:li:member:58472953","geoRegion":"New York City Metropolitan Area","fullName":"Nadira Prashad","firstName":"Nadira","currentPositions":[{"companyName":"Pearl River Laboratories Inc","title":"Associate Director Regulatory CMC","tenureAtCompany":{"numMonths":3},"companyUrnResolutionResult":{"employeeCountRange":"2-10","headquarters":{"geographicArea":"NY","country":"United States","city":"Pearl River","postalCode":"10965","line1":"401 N. Middletown Rd."},"website":"http:\/\/www.pearlriverlabs.com","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/pearl-river-laboratories-inc\/","industry":"Biotechnology Research"},"startedOn":{"month":3,"year":2024},"companyUrn":"urn:li:fs_salesCompany:30722846"}],"entityUrn":"urn:li:fs_salesProfile:(ACwAAAN8OfkBETcBsqLkI2kPVUDqaLQdDsZZMyY,NAME_SEARCH,1YRz)","profilePictureDisplayImage":{"artifacts":[{"width":98,"fileIdentifyingUrlPathSegment":"100_100\/0\/1516635076372?e=1723075200&v=beta&t=BiiYZJym9k6BR--HLVChJBpXWihxFTNnfnpWllpFuh4","height":100},{"width":196,"fileIdentifyingUrlPathSegment":"200_200\/0\/1516635077469?e=1723075200&v=beta&t=MQc2dOlvpx1ZENuVApVtb3XGEUcmEFjqn_msg_GRGIM","height":200},{"width":392,"fileIdentifyingUrlPathSegment":"400_400\/0\/1516635076466?e=1723075200&v=beta&t=gl6xoCe968dUPtWVNfaDEw1UsJS2ojz6acKQIztxvn4","height":400},{"width":441,"fileIdentifyingUrlPathSegment":"800_800\/0\/1516635077060?e=1723075200&v=beta&t=Y2HYt7gg2MItBCMZO_keNdZAQ4tZ6zv8pWDaeyaAnP0","height":450}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/C4D03AQEUmMVj2lG3wg\/profile-displayphoto-shrink_"},"projects":[],"contactInfo":{},"industry":"Pharmaceutical Manufacturing","educations":[{"endedOn":{"year":2019},"degree":"Master of Science - MS","eduId":391121156,"schoolUrn":"urn:li:fs_salesSchool:5274","school":"urn:li:fs_salesSchool:5274","fieldsOfStudy":["Regulatory Affairs for Drug, Biologics and Medical Device"],"schoolName":"Northeastern University","startedOn":{"year":2017}},{"endedOn":{"month":1,"year":2000},"degree":"Bachelor of Applied Science - BASc","eduId":938354083,"schoolUrn":"urn:li:fs_salesSchool:30796","school":"urn:li:fs_salesSchool:30796","fieldsOfStudy":["Chemistry"],"schoolName":"Ramapo College of New Jersey"},{"degree":"Dip Pharm.","schoolUrn":"urn:li:fs_salesSchool:1167967","eduId":43521583,"school":"urn:li:fs_salesSchool:1167967","fieldsOfStudy":["Pharmacy"],"schoolName":"University of Guyana"}],"skills":[{"numOfEndorsement":0,"name":"Team Effectiveness"},{"numOfEndorsement":0,"name":"Problem Solving"},{"numOfEndorsement":0,"name":"Oligonucleotides"},{"numOfEndorsement":0,"name":"International Regulations"},{"numOfEndorsement":0,"name":"Global Drug Development"},{"numOfEndorsement":36,"name":"Chromatography"},{"numOfEndorsement":26,"name":"Pharmaceutical Industry"},{"numOfEndorsement":24,"name":"Drug Development"},{"numOfEndorsement":18,"name":"HPLC"},{"numOfEndorsement":21,"name":"GMP"},{"numOfEndorsement":13,"name":"GLP"},{"numOfEndorsement":14,"name":"Method Development"},{"numOfEndorsement":14,"name":"Chemistry"},{"numOfEndorsement":11,"name":"Laboratory"},{"numOfEndorsement":9,"name":"Dissolution"},{"numOfEndorsement":8,"name":"LIMS"},{"numOfEndorsement":9,"name":"Drug Discovery"},{"numOfEndorsement":11,"name":"Analytical Chemistry"},{"numOfEndorsement":7,"name":"LC-MS"},{"numOfEndorsement":6,"name":"V&V"},{"numOfEndorsement":5,"name":"Biopharmaceuticals"},{"numOfEndorsement":3,"name":"Sop"},{"numOfEndorsement":1,"name":"LC\/MS"},{"numOfEndorsement":3,"name":"Regulatory Affairs"},{"numOfEndorsement":2,"name":"Regulatory Compliance"},{"numOfEndorsement":8,"name":"SOP"},{"numOfEndorsement":3,"name":"Laboratory Skills"},{"numOfEndorsement":2,"name":"Laboratory Information Management System (LIMS)"},{"numOfEndorsement":3,"name":"High-Performance Liquid Chromatography (HPLC)"},{"numOfEndorsement":0,"name":"CMC Regulatory Affairs"},{"numOfEndorsement":0,"name":"CMC"}],"numOfConnections":990,"patents":[],"headline":"Associate Director Regulatory CMC at Pearl River Laboratories Inc","courses":[],"certifications":[],"memberBadges":{"premium":false,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/nadira-prashad-6216ba17","organizations":[],"location":"New York City Metropolitan Area","publications":[],"positions":null,"posts":[{"createdAt":1714179420000,"insightId":"a05c0512-bd4e-494a-a794-3727606c4486","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":3}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7189789621382250497","threadUrn":"urn:li:activity:7189789621382250497","reactionsCount":3,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7189789620832808960","message":{"attributes":[],"text":"Much needed"},"rootActivity":{"contentSummaryUnion":{"ingestedContentSummary":{"image":{"attributes":[{"originalImageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D4E27AQG-hv6pyHuXrw\/articleshare-shrink_800\/0\/1714129482637?e=1717977600&v=beta&t=S6fBisTGxJzGLTz8SNRwigrcUh6ksAn7T1E17fGjoeA","sourceType":"URL","imageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D4E27AQG-hv6pyHuXrw\/articleshare-shrink_800\/0\/1714129482637?e=1717977600&v=beta&t=S6fBisTGxJzGLTz8SNRwigrcUh6ksAn7T1E17fGjoeA"}]},"description":"A one-time dose of BEQVEZ has reduced bleeds post-treatment compared to standard of care with a median of zero bleeds (range 0 to 19) after up to three years of follow-up, providing sustained bleed protection and potentially avoiding years of...","resolvedUrl":"https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/us-fda-approves-pfizers-beqveztm-fidanacogene-elaparvovec","title":"U.S. FDA Approves Pfizer\u2019s BEQVEZ\u2122 (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7189580918976598019","message":{"attributes":[{"length":6,"start":46,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:1185"}}},{"length":3,"start":78,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:4652"}}},{"length":11,"start":176,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:hemophilia"}}}],"text":"It fills me with great pride to announce that Pfizer received its first-ever \nFDA approval for a gene therapy, and now offers a new one-time treatment for eligible adults with #Hemophilia B. \n\u00a0\nPeople with Hemophilia B can face ongoing and burdensome infusions, spontaneous bleeds which interfere with aspects of their life, and other everyday activities many of us take for granted. This approval provides a new one-time treatment option for eligible patients.\n\u00a0\nThe road to this breakthrough has been a 40+ year effort in which we have worked to advance the hemophilia treatment paradigm, anchored in our focus to explore how science can be a force for transformational, positive change for patients. Thank you to the Pfizer colleagues who made this important step possible for people living with Hemophilia B, for the perseverance, focus, rigor, and overall belief that science can change outcomes for people with debilitating conditions."},"entityUrn":"urn:li:share:7189580918976598019"},"entityUrn":"urn:li:share:7189789620832808960"}}},{"createdAt":1713040740000,"insightId":"882d03ad-3299-4f6b-93ee-9add1e7c0ae5","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":13}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7185013728801607680","threadUrn":"urn:li:activity:7185013728801607680","reactionsCount":13,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7185013728411549698","message":{"attributes":[],"text":""},"rootActivity":{"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7184907890439200768","message":{"attributes":[{"length":24,"start":263,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"https:\/\/lnkd.in\/eAHngX8Y"}}}],"text":"Come hear Amar Prashad, President & CSO at Pearl River Laboratories, speak about understanding the evolving priorities of biotech companies at:\n\nNEW YORK LIFE SCIENCES & BIOTECH\nTHU APR 25, 2024\n\nHudson Valley iCampus\n401 N. Middletown Rd.\nPearl River, NY 10965\n\nhttps:\/\/lnkd.in\/eAHngX8Y"},"entityUrn":"urn:li:share:7184907890439200768"},"entityUrn":"urn:li:share:7185013728411549698"}}},{"createdAt":1709604120000,"insightId":"fa3190a0-331f-4385-82da-19b3c219d0d3","activityUnion":{"postActivity":{"contentSummaryUnion":{"referenceContentSummary":{"entityUrn":"urn:li:celebrateJobChange:7170599468529098753"}},"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":77},{"type":"PRAISE","count":22},{"type":"EMPATHY","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:ugcPost:7170599469334413312","threadUrn":"urn:li:ugcPost:7170599469334413312","reactionsCount":100,"commentsCount":95,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7170599469334413312","message":{"attributes":[{"start":92,"length":28,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:30722846"}}}],"text":"I\u2019m happy to share that I\u2019m starting a new position as Associate Director Regulatory CMC at Pearl River Laboratories Inc!"},"entityUrn":"urn:li:ugcPost:7170599469334413312"}}},{"createdAt":1716043140000,"insightId":"b8a8fcb3-d6dd-46f0-b32b-a03f4745bab4","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7194825345647210496,7197606677414563840)","threadUrn":"urn:li:ugcPost:7194825345647210496","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"This is great!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7194825345647210496"}}},{"createdAt":1710806580000,"insightId":"da04db1c-f07b-4af3-b2d0-726d3a803d47","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7170599469334413312,7175642899521359872)","threadUrn":"urn:li:ugcPost:7170599469334413312","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":14,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:133287258"}}}],"text":"Farhad Rahaman Thank You Farhad!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7170599469334413312"}}},{"createdAt":1710806520000,"insightId":"65781883-9e43-4a09-b86a-c83a753642a8","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7170599469334413312,7175642811340345348)","threadUrn":"urn:li:ugcPost:7170599469334413312","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":22,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:12273393"}}}],"text":"Marja van Zeijl, Ph.D. Thank you Marja!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7170599469334413312"}}},{"createdAt":1710806520000,"insightId":"1a3336bb-72f1-497a-b6be-8f3a47d1a244","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7170599469334413312,7175642708974141440)","threadUrn":"urn:li:ugcPost:7170599469334413312","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":15,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:31061816"}}}],"text":"Vidia Roopchand  Thanks Vidia"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7170599469334413312"}}},{"createdAt":1710806340000,"insightId":"73884cc4-3f4f-4e2a-a82a-0331949d5ea4","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7170599469334413312,7175641944281219072)","threadUrn":"urn:li:ugcPost:7170599469334413312","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":11,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:215486908"}}}],"text":"Ava Padmore Thank you Ava!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7170599469334413312"}}},{"createdAt":1710806280000,"insightId":"3d28ef45-9443-4400-b809-8a79f214eca6","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7170599469334413312,7175641664173002752)","threadUrn":"urn:li:ugcPost:7170599469334413312","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":14,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:1213315033"}}}],"text":"Sushma Ghimire Thank you Sushma!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7170599469334413312"}}},{"createdAt":1710806280000,"insightId":"6c22c45e-d9ed-4bbf-93b6-79090071f16c","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7170599469334413312,7175641832293335040)","threadUrn":"urn:li:ugcPost:7170599469334413312","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":9,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:197884915"}}}],"text":"Dionne G. Thanks Dionne."},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7170599469334413312"}}},{"createdAt":1710806220000,"insightId":"0d6e9ac1-3862-4b00-b9b3-ca512b92384a","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7170599469334413312,7175641449126887425)","threadUrn":"urn:li:ugcPost:7170599469334413312","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":16,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:22849325"}}}],"text":"Maria Figueiredo Hi Maria Thank you!!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7170599469334413312"}}},{"createdAt":1710806160000,"insightId":"b1153597-ff4b-4736-8e87-4b55d8491873","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7170599469334413312,7175641134445031424)","threadUrn":"urn:li:ugcPost:7170599469334413312","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":16,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:22105381"}}}],"text":"Nataliya Bazhina Hi Nataliya Thank you."},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7170599469334413312"}}},{"createdAt":1710806160000,"insightId":"b33557db-092d-4a30-82d2-6fed07dea43e","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7170599469334413312,7175641328905547776)","threadUrn":"urn:li:ugcPost:7170599469334413312","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":9,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:183421346"}}}],"text":"Kim Kafka Thank you so much Kim!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7170599469334413312"}}},{"createdAt":1710806100000,"insightId":"a770c73a-3482-42e7-9597-1aaa5721b478","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7170599469334413312,7175640921357594624)","threadUrn":"urn:li:ugcPost:7170599469334413312","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":6,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:10310966"}}}],"text":"Wei Z. Thank you Wei!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7170599469334413312"}}},{"createdAt":1710806100000,"insightId":"1739b1d2-fb8e-407e-8e3d-b9d117778299","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7170599469334413312,7175641012579512321)","threadUrn":"urn:li:ugcPost:7170599469334413312","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":12,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:555070291"}}}],"text":"Edel Shannon  Thanks Edel!!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7170599469334413312"}}},{"createdAt":1710806040000,"insightId":"832f324a-e25f-435e-af86-79aba784838e","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7170599469334413312,7175640668415873024)","threadUrn":"urn:li:ugcPost:7170599469334413312","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":13,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:96282437"}}}],"text":"Suroj Hoffman thank you Suroj!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7170599469334413312"}}},{"createdAt":1710806040000,"insightId":"93c715bc-0f91-4f9d-9dbb-4cc42587060c","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7170599469334413312,7175640821822562304)","threadUrn":"urn:li:ugcPost:7170599469334413312","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":13,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:16729693"}}}],"text":"Kaushik Dutta Thank you Kaushik!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7170599469334413312"}}},{"createdAt":1710805980000,"insightId":"7b3dfcdc-a743-457d-a937-f5e8e9f8c111","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7170599469334413312,7175640552942489601)","threadUrn":"urn:li:ugcPost:7170599469334413312","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":17,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:9450382"}}}],"text":"Shridhar Gangolli  Thanks Shridhar!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7170599469334413312"}}},{"createdAt":1710805980000,"insightId":"40d04805-287f-4cb1-a0c8-572b9768b294","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7170599469334413312,7175640447631949824)","threadUrn":"urn:li:ugcPost:7170599469334413312","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":14,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:14812390"}}}],"text":"Robert Mentore Thank you Rob!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7170599469334413312"}}}]}